By Mariana Lenharo
Source Nature
Early this month, a scientific publisher retracted two studies1,2 cited by a federal judge in Texas when he ruled that the abortion pill mifepristone should be taken off the market, suggesting that the drug causes a burden on the public-health system. It also retracted a third3 that surveyed abortion providers in Florida, linking them to malpractice and disciplinary issues. According to Sage Publications, the first two papers had problems with study design and methodology and errors in data analysis. And all three included unsupported assumptions and misleading data presentations. In addition, the studies’ authors, many of whom are affiliated with anti-abortion organizations, failed to declare conflicts of interest, Sage said in its retraction notice.
Read more https://www.nature.com/articles/d41586-024-00556-0